Jefferson University Hospitals

Physician Profile

Charles Pollack, MD

Jefferson University Physician

Academic Title: Professor

Specialties
Emergency Medicine

Make An Appointment

Click to call 1-800-JEFF-NOW (800-533-3669) or

Office Locations

Philadelphia
2301 S. Broad Street
Philadelphia PA 19148
Phone: (215) 952-9130
Fax: (215) 952-5193
Philadelphia
239 Thompson Building
Philadelphia PA 19107
Phone: (215) 955-6844
Fax: (215) 923-6225

Medical Services

Board Certifications

  • Emergency Medicine

Hospital Affiliation / Admitting Privileges

  • Thomas Jefferson University Hospital
  • Methodist Hospital Division of Thomas Jefferson University Hospital

Education

  • Tulane University School of Medicine, Medical School

Internship

  • Naval Hospital, San Diego, CA

Residency

  • University of Mississippi Medical Center

Recent Publications

Idarucizumab for dabigatran reversal -full cohort analysis

Relative efficacy and safety of ticagelor vs clopidogrel as a function of time to invasive management in non–ST-segment elevation acute coronary syndrome in the PLATO trial

Healthcare resource utilization in patients receiving idarucizumab for reversal of dabigatran anticoagulation due to major bleeding, urgent surgery, or procedural interventions: interim results from the RE-VERSE AD™ study

Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention

Successful use of idarucizumab as a reversal agent for dabigatran in a patient with acute dissected aortic aneurysm

Intravenous Enoxaparin Versus Unfractionated Heparin in Elderly Patients Undergoing Primary Percutaneous Coronary Intervention

Evidence supporting idarucizumab for the reversal of dabigatran

Introduction to Direct Oral Anticoagulants and Rationale for Specific Reversal Agents

Evidence Supporting Idarucizumab for the Reversal of Dabigatran

Multicenter Trial of Rivaroxaban for Early Discharge of Pulmonary Embolism From the Emergency Department (MERCURY PE): Rationale and Design

Idarucizumab for dabigatran overdose

Apixaban compared with parenteral heparin and/or vitamin K antagonist in patients with nonvalvular atrial fibrillation undergoing cardioversion: Rationale and design of the EMANATE trial

Inhaled loxapine for the urgent treatment of acute agitation associated with schizophrenia or bipolar disorder

Coagulation assessment with the new generation of oral anticoagulants

Association of early stress testing with outcomes for emergency department evaluation of suspected acute coronary syndrome

Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation

Identification of Patient Characteristics Influencing Setting of Care Decisions for Patients with Acute Bacterial Skin and Skin Structure Infections: Results of a Discrete Choice Experiment

Patient-reported Outcomes from A National, Prospective, Observational Study of Emergency Department Acute Pain Management with an Intranasal Nonsteroidal Anti-inflammatory Drug, Opioids, or Both

Antidotes for Bleeding Caused by Novel Oral Anticoagulants

Letter to the Editor: Managing Dabigatran-Related Bleeding